Endologix Inc. has resumed shipping of some of its AFX endovascular abdominal aortic aneurysm systems, after placing the devices on hold. This brought an end to a rather tumultuous week for the Irvine, Calif.-based company's stock (NASDAQ: ELGX), which plummeted as much as 27 percent upon news of the hold. However, shares of the stock slightly rebounded late last week. (See Medical Device Daily, Dec. 28, 2016.) Read More
